Literature DB >> 29548551

Myocardial late gadolinium enhancement: a head-to-head comparison of motion-corrected balanced steady-state free precession with segmented turbo fast low angle shot.

H Fan1, S Li2, M Lu3, G Yin2, X Yang2, T Lan2, L Dai2, X Chen2, J Li2, Y Zhang2, A Sirajuddin4, P Kellman5, A E Arai4, S Zhao6.   

Abstract

AIM: To evaluate the image quality and diagnostic agreement with a head-to-head comparison of late gadolinium enhancement (LGE) images acquired by the motion-corrected (MOCO) balanced steady-state free precession (bSSFP) phase sensitivity inversion recovery (PSIR) and conventional segmented fast low angle shot (FLASH) PSIR methods15,16 in a patient cohort with a wide spectrum of cardiovascular disease.
MATERIALS AND METHODS: In 59 consecutive patients, signal-to-noise ratios (SNRs), contrast-to-noise ratios (CNRs) of the normal myocardium (NM), LGE, and blood pool (BP) were pair-wise compared between the two different sequences. A further semi-qualitative score system (graded 1 -4) was used to compare the overall image quality (OIQ). The diagnostic agreement of the two techniques were evaluated by both transmural severity and absolutely quantitative size of LGE.
RESULTS: The SNRs of the NM, LGE, and BP of MOCO bSSFP were 4.8±3.4, 53.6±35.6 and 43.2±29.3, compared with 3.9±3.6 (p=0.126), 27.7±18.5 (p<0.001) and 24.3±13.4 (p<0.001) of FLASH LGE, respectively. The CNRs of LGE to NM, LGE to BP, and BP to NM were 48.3±33.1 versus 23.8±16.7 (p<0.001), 6.5±21.6 versus 3.8±10.8 (p<0.001), and 38.3±27.2 versus 20.3±10.7 (p=0.448), respectively. The OIQ of MOCO bSSFP was higher than that of segmented FLASH (median 4 versus median 3, p<0.001). For quantification of LGE size, there is good agreement and high correlation (r=0.992, p<0.001) between the two methods.
CONCLUSIONS: MOCO bSSFP is a feasible, robust sequence for LGE imaging, especially for patients with arrhythmia and those incapable of breath-holding due to severe heart failure.
Copyright © 2018 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29548551     DOI: 10.1016/j.crad.2018.02.002

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

1.  Free-Breathing Motion-Corrected Single-Shot Phase-Sensitive Inversion Recovery Late-Gadolinium-Enhancement Imaging: A Prospective Study of Image Quality in Patients with Hypertrophic Cardiomyopathy.

Authors:  Min Jae Cha; Iksung Cho; Joonhwa Hong; Sang Wook Kim; Seung Yong Shin; Mun Young Paek; Xiaoming Bi; Sung Mok Kim
Journal:  Korean J Radiol       Date:  2021-04-01       Impact factor: 3.500

2.  Ischemic Heart Disease: Noninvasive Imaging Techniques and Findings.

Authors:  Arlene Sirajuddin; S Mojdeh Mirmomen; Seth J Kligerman; Daniel W Groves; Allen P Burke; Faraz Kureshi; Charles S White; Andrew E Arai
Journal:  Radiographics       Date:  2021-05-21       Impact factor: 6.312

3.  Prognosis in patients with coronary heart disease and breath-holding limitations: a free-breathing cardiac magnetic resonance protocol at 3.0 T.

Authors:  Keyan Wang; Wenbo Zhang; Shuman Li; Xiaoming Bi; Michaela Schmidt; Jing An; Jie Zheng; Jingliang Cheng
Journal:  BMC Cardiovasc Disord       Date:  2021-12-07       Impact factor: 2.298

4.  Prognostic Significance of Left Ventricular Fibrosis Assessed by T1 Mapping in Patients with Atrial Fibrillation and Heart Failure.

Authors:  Lei Zhao; Songnan Li; Xiaohai Ma; Rong Bai; Nian Liu; Ning Li; Paul Schoenhagen; Changsheng Ma
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

5.  Motion-corrected free-breathing late gadolinium enhancement combined with a gadolinium contrast agent with a high relaxation rate: an optimized cardiovascular magnetic resonance examination protocol.

Authors:  Cui Yan; Junjiao Hu; Yanyu Li; Xingzhi Xie; Zhimin Zou; Qiyu Deng; Xiaoyue Zhou; Xiaoming Bi; Mu Zeng; Jun Liu
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.